MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling

[1]  Xin-chun Yang,et al.  The Elabela-APJ axis: a promising therapeutic target for heart failure , 2020, Heart Failure Reviews.

[2]  Quynh Nguyen,et al.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System , 2020, Circulation research.

[3]  Circulating MicroRNA , 2020, Definitions.

[4]  T. Tian,et al.  SIRT6 protects vascular endothelial cells from angiotensin II-induced apoptosis and oxidative stress by promoting the activation of Nrf2/ARE signaling. , 2019, European journal of pharmacology.

[5]  Jingyu Yang,et al.  MicroRNA-122 promotes endothelial cell apoptosis by targeting XIAP: Therapeutic implication for atherosclerosis. , 2019, Life sciences.

[6]  P. Delafontaine,et al.  Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscle. , 2019, Journal of applied physiology.

[7]  Zheng Ma,et al.  Gender Differences in Hypertension , 2019, Journal of Cardiovascular Translational Research.

[8]  K. Zhang,et al.  MiR-122 regulates cell apoptosis and ROS by targeting DJ-1 in renal ischemic reperfusion injury rat models. , 2020, European review for medical and pharmacological sciences.

[9]  J. Reckelhoff.  Gender differences in hypertension , 2018, Current opinion in nephrology and hypertension.

[10]  Hong-zhao Li,et al.  miR‐122 promotes metastasis of clear‐cell renal cell carcinoma by downregulating Dicer , 2018, International journal of cancer.

[11]  J. Penninger,et al.  Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and Dysfunction , 2017, Hypertension.

[12]  J. Zhong,et al.  The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling , 2017, Oncotarget.

[13]  L. Servillo,et al.  SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection. , 2017, Antioxidants & redox signaling.

[14]  A. Fukamizu,et al.  ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage , 2017, Cardiovascular research.

[15]  Q. Pang,et al.  SIRT6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox‐LDL condition , 2017, The FEBS journal.

[16]  R. Glen,et al.  Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension , 2017, Circulation.

[17]  G. Oudit,et al.  Ascending aortic adventitial remodeling and fibrosis are ameliorated with Apelin-13 in rats after TAC via suppression of the miRNA-122 and LGR4-β-catenin signaling , 2016, Peptides.

[18]  A. Choi,et al.  Enhanced autophagy in pulmonary endothelial cells on exposure to HIV-Tat and morphine: Role in HIV-related pulmonary arterial hypertension , 2016, Autophagy.

[19]  J. Humphrey,et al.  Excessive Adventitial Remodeling Leads to Early Aortic Maladaptation in Angiotensin-Induced Hypertension , 2016, Hypertension.

[20]  M. Grant,et al.  Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. , 2016, Circulation research.

[21]  S. Efroni,et al.  Reciprocal Regulation between SIRT6 and miR-122 Controls Liver Metabolism and Predicts Hepatocarcinoma Prognosis. , 2016, Cell reports.

[22]  D. Su,et al.  The roles of macrophage autophagy in atherosclerosis , 2016, Acta Pharmacologica Sinica.

[23]  Y. Li,et al.  A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells , 2015, Autophagy.

[24]  M. Netea,et al.  Modulation of inflammation by autophagy: Consequences for human disease , 2015, Autophagy.

[25]  M. Ozen,et al.  Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension , 2015, Medicine.

[26]  Xia Li,et al.  Characterization and Functions of Vascular Adventitial Fibroblast Subpopulations , 2015, Cellular Physiology and Biochemistry.

[27]  Masaharu Kataoka,et al.  Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease , 2014, Cells.

[28]  T. Preiss,et al.  miRNAs in cardiac disease: Sitting duck or moving target? , 2012, IUBMB life.

[29]  M. Lappas.  Anti-Inflammatory Properties of Sirtuin 6 in Human Umbilical Vein Endothelial Cells , 2012, Mediators of inflammation.

[30]  J. Penninger,et al.  Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction , 2010, Circulation.

[31]  D. Klionsky,et al.  Autophagy and Human Disease , 2007, Cell cycle.

[32]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[33]  PhD M. Hibbert,et al.  Gender Differences , 1981, Language in Society.

[34]  C. Indolfi,et al.  Circulating microRNAs as Biomarkers in Cardiovascular Diseases. , 2015, Experientia supplementum.

[35]  Ernesto L. Schiffrin,et al.  Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis , 2001, Hypertension.